Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading & Demat Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Evoq Remedies IPO.
April 18, 2024 3:44:00 AM
Ibotta and shareholders sold 6.56 million shares for $88 each, Bloomberg reported, exceeding the company�s estimated IPO price, which was put between $76 and $84. Selling the shares for $88 each ...
Published by : ForbesApril 19, 2024 6:30:00 PM
The company raised around $200 million in its IPO, despite the overall size being $600 million. Ibotta is a profitable digital marketing company that allows consumer packaged goods companies to ...
Published by : Seeking AlphaApril 18, 2024 9:46:00 PM
Ibotta began its path as a public company on Thursday by opening at $117 per share, a big increase from its IPO price of $88, itself an increase from its proposed range of $76 to $84 per share.
Published by : TechCrunchApril 19, 2024 2:34:00 AM
It just so happens the IPO market perked up just in time for its offering. Ibotta offers cash-back rewards and rebates for purchases at stores that include Walmart, Dollar General and Kroger.
Published by : Wall Street JournalApril 16, 2024 5:50:00 PM
On December 4, 2023, Southwest Gas Holdings, Inc. announced its plan to pursue an initial public offering (IPO) of Centuri Holdings. On March 22, 2024, Centuri Holdings, Inc. (Utility ...
Published by : ForbesApril 19, 2024 6:08:00 PM
Here's a look back at its history and how an investment in its initial public offering (IPO) would have fared. What Happened: Netflix ended the first quarter of 2024 with 269.60 million paid ...
Published by : Benzinga.comApril 10, 2024 11:30:00 AM
The Japanese owner of 7-Eleven, Seven & i Holdings, is considering listing its superstore business as part of efforts to focus on its convenience-store segment. The company, which also owns other ...
Published by : Wall Street JournalApril 18, 2024 8:51:00 PM
Besides looking at how to buy shares of Cerebras stock, investors will want to consider when the company plans to hold its initial public offering (IPO) and whether alternative investment ...
Published by : The Motley FoolApril 19, 2024 12:23:00 AM
Ibotta Inc. climbed 17% in its trading debut after the digital marketing software firm and a group of shareholders raised about $577.3 million in an initial public offering priced above a marketed ...
Published by : Bloomberg L.P.The IPO Shares of Evoq Remedies Limited IPO are proposed to list on Wednesday, March 30, 2022 at BSE SME. The public issue of Evoq Remedies IPO was opened on Mar 17, 2022 and closed for subscription on Mar 22, 2022. Evoq Remedies IPO Listing Date and Information:
| Listing Date | Wednesday, March 30, 2022 |
| BSE Script Code | 543500 |
| NSE Symbol | |
| Listing In | MT Group of Securities |
| ISIN | INE0JVD01011 |
| Issue Price | ₹27 Per Equity Share |
| Face Value | ₹10 Per Equity Share |
The allotment status of Evoq Remedies Limited IPO is now available online. The public issue of Evoq Remedies IPO was open on Mar 17, 2022 and closed for subscription on Mar 22, 2022. The equity shares of the company to be list at BSE SME.
Evoq Remedies Limited is entering in the capital market with an IPO of 3,600,000 Equity Shares of Rs 10 aggregating up to Rs 9.72 Crore. The price for the issue has been set at Rs 27 Per Equity Share.
Incorporated in 2010, EVOQ Remedies Limited specializes in offering quality Pharmaceuticals Raw Material products, Excipients, and Bulk Drugs at an affordable prices. The company procures all the products from WHO-GMP certified & reliable Manufacturers & Importers, who follow procedures as per the stringent national and international quality and safety standards.
The issue opens on Mar 17, 2022 and closes for subscription on Mar 22, 2022. The equity shares of the company to be list at BSE SME.
The issue of Evoq Remedies Limited opens on Mar 17, 2022 and closes for subscription on Mar 22, 2022. The equity shares of the company to be list at BSE SME. The price for the issue has been set at Rs 27 Per Equity Share.
The Evoq Remedies IPO is proposed to open on March 17, 2022. The IPO application ends on March 22, 2022.
Retail investors can apply in the retail or non-institutional investor category from March 17, 2022 to March 22, 2022. The Evoq Remedies IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Evoq Remedies IPO will open for subscription on March 17, 2022. The public issue will close on March 22, 2022.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
